139 related articles for article (PubMed ID: 9438909)
1. Dermal fibroblasts from venous ulcers are unresponsive to the action of transforming growth factor-beta 1.
Hasan A; Murata H; Falabella A; Ochoa S; Zhou L; Badiavas E; Falanga V
J Dermatol Sci; 1997 Nov; 16(1):59-66. PubMed ID: 9438909
[TBL] [Abstract][Full Text] [Related]
2. Regulation of matrix contraction in chronic venous disease.
Pappas PJ; Lal BK; Ohara N; Saito S; Zapiach L; Durán WN
Eur J Vasc Endovasc Surg; 2009 Oct; 38(4):518-29. PubMed ID: 19560950
[TBL] [Abstract][Full Text] [Related]
3. Extravasation of macromolecules and possible trapping of transforming growth factor-beta in venous ulceration.
Higley HR; Ksander GA; Gerhardt CO; Falanga V
Br J Dermatol; 1995 Jan; 132(1):79-85. PubMed ID: 7538779
[TBL] [Abstract][Full Text] [Related]
4. Effect of healing on the expression of transforming growth factor beta(s) and their receptors in chronic venous leg ulcers.
Cowin AJ; Hatzirodos N; Holding CA; Dunaiski V; Harries RH; Rayner TE; Fitridge R; Cooter RD; Schultz GS; Belford DA
J Invest Dermatol; 2001 Nov; 117(5):1282-9. PubMed ID: 11710945
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta 1, 2, 3 and receptor type I and II in diabetic foot ulcers.
Jude EB; Blakytny R; Bulmer J; Boulton AJ; Ferguson MW
Diabet Med; 2002 Jun; 19(6):440-7. PubMed ID: 12060054
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2).
Strutz F; Zeisberg M; Renziehausen A; Raschke B; Becker V; van Kooten C; Müller G
Kidney Int; 2001 Feb; 59(2):579-92. PubMed ID: 11168939
[TBL] [Abstract][Full Text] [Related]
7. [Effects of silencing Smad ubiquitination regulatory factor 2 on the function of human hypertrophic scar-derived fibroblasts].
Zhang Z; Kuang F; Liu CL; Chen B; Tang WB; Li XJ
Zhonghua Shao Shang Za Zhi; 2017 Mar; 33(3):145-151. PubMed ID: 28316163
[No Abstract] [Full Text] [Related]
8. Insulin-like growth factor-II/mannose 6 phosphate receptors facilitate the matrix effects of latent transforming growth factor-beta1 released from genetically modified keratinocytes in a fibroblast/keratinocyte co-culture system.
Ghahary A; Tredget EE; Shen Q
J Cell Physiol; 1999 Jul; 180(1):61-70. PubMed ID: 10362018
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta promotes deposition of collagen VII in a modified organotypic skin model.
König A; Bruckner-Tuderman L
Lab Invest; 1994 Feb; 70(2):203-9. PubMed ID: 8139261
[TBL] [Abstract][Full Text] [Related]
10. Altered proliferative responses of dermal fibroblasts to TGF-beta1 may contribute to chronic venous stasis ulcer.
Lal BK; Saito S; Pappas PJ; Padberg FT; Cerveira JJ; Hobson RW; Durán WN
J Vasc Surg; 2003 Jun; 37(6):1285-93. PubMed ID: 12764277
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta 1 induces the expression of type I collagen and SPARC, and enhances contraction of collagen gels, by fibroblasts from young and aged donors.
Reed MJ; Vernon RB; Abrass IB; Sage EH
J Cell Physiol; 1994 Jan; 158(1):169-79. PubMed ID: 8263022
[TBL] [Abstract][Full Text] [Related]
12. Keratinocytes suppress transforming growth factor-beta1 expression by fibroblasts in cultured skin substitutes.
Le Poole IC; Boyce ST
Br J Dermatol; 1999 Mar; 140(3):409-16. PubMed ID: 10233258
[TBL] [Abstract][Full Text] [Related]
13. Connective tissue growth factor siRNA modulates mRNA levels for a subset of molecules in normal and TGF-beta 1-stimulated porcine skin fibroblasts.
Wang JF; Olson ME; Ma L; Brigstock DR; Hart DA
Wound Repair Regen; 2004; 12(2):205-16. PubMed ID: 15086772
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta 1 stimulates cultured human fibroblasts to proliferate and produce tissue-like fibroplasia: a fibronectin matrix-dependent event.
Clark RA; McCoy GA; Folkvord JM; McPherson JM
J Cell Physiol; 1997 Jan; 170(1):69-80. PubMed ID: 9012786
[TBL] [Abstract][Full Text] [Related]
15. Effect of interleukin-10 on the gene expression of type I collagen, fibronectin, and decorin in human skin fibroblasts: differential regulation by transforming growth factor-beta and monocyte chemoattractant protein-1.
Yamamoto T; Eckes B; Krieg T
Biochem Biophys Res Commun; 2001 Feb; 281(1):200-5. PubMed ID: 11178980
[TBL] [Abstract][Full Text] [Related]
16. A novel truncated TGF-beta receptor II downregulates collagen synthesis and TGF-beta I secretion of keloid fibroblasts.
Chu Y; Guo F; Li Y; Li X; Zhou T; Guo Y
Connect Tissue Res; 2008; 49(2):92-8. PubMed ID: 18382895
[TBL] [Abstract][Full Text] [Related]
17. Antagonistic effects of TNF-alpha on TGF-beta signaling through down-regulation of TGF-beta receptor type II in human dermal fibroblasts.
Yamane K; Ihn H; Asano Y; Jinnin M; Tamaki K
J Immunol; 2003 Oct; 171(7):3855-62. PubMed ID: 14500687
[TBL] [Abstract][Full Text] [Related]
18. IFN-gamma fails to antagonize fibrotic effect of TGF-beta on keloid-derived dermal fibroblasts.
Hasegawa T; Nakao A; Sumiyoshi K; Tsuboi R; Ogawa H
J Dermatol Sci; 2003 Jun; 32(1):19-24. PubMed ID: 12788525
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: antagonism by IFN-alpha and IFN-gamma in vitro and in vivo.
Tredget EE; Wang R; Shen Q; Scott PG; Ghahary A
J Interferon Cytokine Res; 2000 Feb; 20(2):143-51. PubMed ID: 10714549
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
